Peer review process
Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.
Read more about eLife’s peer review process.Editors
- Reviewing EditorJames SellersNational Institutes of Health, Bethesda, United States of America
- Senior EditorBenoît KornmannUniversity of Oxford, Oxford, United Kingdom
Reviewer #1 (Public Review):
Interactions known to be important for melanosome transport include exon F and the globular tail domain (GTD) of MyoVa with Mlph. Motivated by a discrepancy between in vitro and cell culture results regarding necessary interactions for MyoVa to be recruited to the melanosome, the authors used a series of pull-down and pelleting assays experiments to identify an additional interaction that occurs between exon G of MyoVa and Mlph. This interaction is independent of and synergistic with the interaction of Mlph with exon F. However, the interaction of the actin-binding domain of Mlph can occur either with exon G or with the actin filament, but not both simultaneously. These data lead to a modified recruitment model where both exon F and exon G enhance the binding of Mlph to auto-inhibited MyoVa, and then via an unidentified switch (PKA?) the actin-binding domain of Mlph dissociates from MyoVa and interacts with the actin filament to enhance MyoVa processivity.
The only weakness noted is that the authors could have had a more complete story if they pursued whether PKA phosphorylation/dephosphorylation of Mlph is indeed the switch for the actin-binding domain of Mlph to interact with exon G versus the actin filament.
Reviewer #2 (Public Review):
The authors identify a third component in the interaction between myosin Va and melanophilin- an interaction between a 32-residue sequence encoded by exon-g in myosin Va and melanophilin's actin-binding domain. This interaction has implications for how melanosome motility may be regulated.
While this work is largely well done, I believe that additional work would be required to make a more compelling case (e.g. some affinity measurements, necessary controls for the dominant negative experiments). First, the study provides just one more piece to a well-developed story (the role of exon-F and the GTD in myosin Va: melanophilin (Mlph) interaction), much of which was published 20 years ago by several labs. Second, the study does not demonstrate a physiological significance for their findings other than that exon-G plays an auxiliary role in the binding of myosin Va to Mlph. For example, what dictates the choice between Mlph's actin binding domain (ABD) binding to actin or to exon-G. Is it a PTM or local actin concentration? It is unlikely to be alternative splicing as exon-G is present in all spliced isoforms of myosin Va. And what changes re melanosome dynamics in cells between these two alternatives? Similarly, the paper does not provide any in vitro evidence that binding to exon-G instead of actin effects the processivity of a Rab27a/Myosin Va/Mlph transport complex. For example, if the ABD sticks to exon-G instead of actin, does that block Mlph's ability to promote processivity through its interaction with the actin filament during transport? In summary, given that the authors did not directly test their model either in vitro or in cells, I do not think this story represent a significant conceptual advance.